57296-46-5 Usage
Molecular weight
255.04 g/mol
Appearance
White or off-white crystalline solid
Solubility
Soluble in polar solvents like water and ethanol
Melting point
Approximately 190-200°C
Boiling point
Not readily available, but expected to be high due to the presence of multiple functional groups
Density
Not readily available, but expected to be higher than water due to the presence of heavy chlorine atoms
Functional groups
Carboxylic acid, chlorine, and methoxy groups
Chemical structure
A benzene ring with two carboxylic acid groups at the 1 and 2 positions, two chlorine atoms at the 3 and 4 positions, and a methoxy group at the 5 position
Applications
Production of polymers and plastics with enhanced heat resistance and durability
Building block for the synthesis of pharmaceuticals and agrochemicals
Safety precautions
Harmful if it comes into contact with the skin or eyes
Use in a well-ventilated area to avoid inhalation of vapors or dust
Wear appropriate personal protective equipment (PPE) such as gloves, goggles, and a mask when handling
Storage
Store in a cool, dry, and well-ventilated area, away from direct sunlight and heat sources
Stability
Stable under normal conditions, but may decompose upon exposure to high temperatures or strong oxidizing agents
Reactivity
Reacts with bases, reducing agents, and nucleophiles due to the presence of carboxylic acid and chlorine functional groups
Check Digit Verification of cas no
The CAS Registry Mumber 57296-46-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,2,9 and 6 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 57296-46:
(7*5)+(6*7)+(5*2)+(4*9)+(3*6)+(2*4)+(1*6)=155
155 % 10 = 5
So 57296-46-5 is a valid CAS Registry Number.
57296-46-5Relevant academic research and scientific papers
Woltersdorf, O. W.,deSolms, S. J.,Stokker, G. E.,Cragoe, E. J.
, p. 840 - 845 (1984)
Investigation of the chemistry of the potent uricosuric diuretic indacrinone (MK-196) prompted the synthesis of a series of 3-oxo derivatives, i.e., the indan-1,3-diones.In general, both pharmacological parameters (uricosuria and diuresis) were significantly less pronounced with the 1,3-diones than with the parent 1-oxo compounds
(1-Oxo-7,8-disubstituted-1,2,3,4-tetrahydro-6-naphthyloxy)- and (3,4-disubstituted-5-oxo-6,7,8,9-tetrahydro-5H-benzocycloheptene-2-yloxy) acetic acids and derivatives
-
, (2008/06/13)
(1-Oxo-7,8-disubstituted-1,2,3,4-tetrahydro-6-naphthyloxy)- and (3,4-disubstituted-5-oxo-6,7,8,9-tetrahydro-5H-benzocyclohepten-2-yloxy)acetic acids, their carboxylate salts, and the amide and 5-tetrazole derivatives thereof are active as diuretic and sal
Pharmaceutical compositions and method of treatment employing 1,3-dioxo-2,2-disubstituted indanyloxy alkanoic acids
-
, (2008/06/13)
[1,3-Dioxo-2-substituted and 2,2-disubstituted-indanyloxy(or thio)]alkanoic acids and their salts, esters and amides are disclosed. The products display a dual pharmaceutical utility in that they exhibit diuretic, saluretic and uricosuric activity. The ac